Holdings
Acorn Capital Advisors, LLC
As of Sep 30, 2026, Acorn Capital Advisors, LLC reported 19 positions worth US$289M. Largest: CG Oncology, Inc., Puma Biotechnology Inc and Candel Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| CG Oncology, Inc. | 1.13M | US$80.2M | no change | Sep 30, 2026 |
| Puma Biotechnology Inc | 4.13M | US$41M | no change | Sep 30, 2026 |
| Candel Therapeutics, Inc. | 3.5M | US$36.5M | no change | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 2.14M | US$30.7M | no change | Sep 30, 2026 |
| Cybin, Inc. | 1.54M | US$18.9M | no change | Sep 30, 2026 |
| Jade Biosciences, Inc. | 987K | US$13.9M | no change | Sep 30, 2026 |
| Bicara Therapeutics Inc. | 668K | US$12.4M | +25,000 | Sep 30, 2026 |
| Verastem, Inc. | 1.47M | US$11.8M | no change | Sep 30, 2026 |
| OnKure Therapeutics, Inc. | 2.84M | US$7.75M | no change | Sep 30, 2026 |
| AN2 Therapeutics, Inc. | 1.3M | US$6.92M | new | Sep 30, 2026 |